These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6593071)

  • 1. A novel biologically active seleno-organic compound--III. Effects of PZ 51 (Ebselen) on glutathione peroxidase and secretory activities of mouse macrophages.
    Parnham MJ; Kindt S
    Biochem Pharmacol; 1984 Oct; 33(20):3247-50. PubMed ID: 6593071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel biologically active seleno-organic compound--II. Activity of PZ 51 in relation to glutathione peroxidase.
    Wendel A; Fausel M; Safayhi H; Tiegs G; Otter R
    Biochem Pharmacol; 1984 Oct; 33(20):3241-5. PubMed ID: 6487371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen).
    Müller A; Cadenas E; Graf P; Sies H
    Biochem Pharmacol; 1984 Oct; 33(20):3235-9. PubMed ID: 6487370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel biologically active seleno-organic compound--V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase.
    Safayhi H; Tiegs G; Wendel A
    Biochem Pharmacol; 1985 Aug; 34(15):2691-4. PubMed ID: 2990494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic seleno-organic compound with glutathione peroxidase-like activity in the chick.
    Mercurio SD; Combs GF
    Biochem Pharmacol; 1986 Dec; 35(24):4505-9. PubMed ID: 3098252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebselen: a new approach to the inhibition of peroxide-dependent inflammation.
    Parnham MJ; Leyck S; Kuhl P; Schalkwijk J; van den Berg WB
    Int J Tissue React; 1987; 9(1):45-50. PubMed ID: 3036734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of superoxide anion production in guinea pig polymorphonuclear leukocytes by a seleno-organic compound, ebselen.
    Ichikawa S; Omura K; Katayama T; Okamura N; Ohtsuka T; Ishibashi S; Masayasu H
    J Pharmacobiodyn; 1987 Oct; 10(10):595-7. PubMed ID: 2831335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some aspects of cardiac antioxidant defence: Ebselen (PZ 51) treatment increases glutathione peroxidase activity in the rat heart.
    Hermenegildo C; Nies E; Monsalve E; Puertas FJ; Higueras V; Romero FJ
    Biochem Soc Trans; 1990 Dec; 18(6):1193-4. PubMed ID: 2088859
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrophage, lymphocyte and chronic inflammatory responses in selenium deficient rodents. Association with decreased glutathione peroxidase activity.
    Parnham MJ; Winkelmann J; Leyck S
    Int J Immunopharmacol; 1983; 5(5):455-61. PubMed ID: 6654541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the relative contributions of the diselenide and selenol forms of ebselen in the mechanism of its glutathione peroxidase-like activity.
    Morgenstern R; Cotgreave IA; Engman L
    Chem Biol Interact; 1992 Sep; 84(1):77-84. PubMed ID: 1394617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
    Pratta MA; Ackerman NR; Arner EC
    Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of superoxide anion radical production by ebselen (PZ51) and its sulfur analogue (PZ25) in guinea pig alveolar macrophages.
    Leurs R; Timmerman H; Bast A
    Biochem Int; 1989 Feb; 18(2):295-9. PubMed ID: 2548505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine and glutathione-dependent protective effect of PZ51 (Ebselen) against diquat-induced cytotoxicity in isolated hepatocytes.
    Cotgreave IA; Sandy MS; Berggren M; Moldéus PW; Smith MT
    Biochem Pharmacol; 1987 Sep; 36(18):2899-904. PubMed ID: 3632716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen.
    Leyck S; Parnham MJ
    Agents Actions; 1990 Jun; 30(3-4):426-31. PubMed ID: 2117337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel biologically active seleno-organic compound--VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice.
    Wendel A; Tiegs G
    Biochem Pharmacol; 1986 Jul; 35(13):2115-8. PubMed ID: 3729968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebselen has dehydroascorbate reductase and thioltransferase-like activities.
    Jung CH; Washburn MP; Wells WW
    Biochem Biophys Res Commun; 2002 Mar; 291(3):550-3. PubMed ID: 11855823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoke-induced alterations in the release of arachidonate metabolites by pulmonary alveolar macrophage from selenium-fed and selenium-deficient rats.
    Gairola CG; Tai HH
    Biochem Pharmacol; 1986 Jul; 35(14):2423-8. PubMed ID: 3015150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of ebselen against anoxic damage of cultured neurons of cerebral cortex.
    Tan YX; Li WH; Tao XB; Jiang YY; Chen WP; Zhou B
    Zhongguo Yao Li Xue Bao; 1997 May; 18(3):201-3. PubMed ID: 10072932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats.
    Saad SY; Najjar TA; Arafah MM
    Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):412-7. PubMed ID: 17169121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen.
    Nozawa R; Arai M; Kuruto R; Motohashi T; Masayasu H
    J Pharm Pharmacol; 1996 Jan; 48(1):64-7. PubMed ID: 8722498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.